Menu Search
Equities

Health Catalyst Inc

2YP:DEU

Health Catalyst Inc

Actions
  • Price (EUR)7.80
  • Today's Change-0.150 / -1.89%
  • Shares traded0.00
  • 1 Year change+21.88%
  • Beta--
Data delayed at least 15 minutes, as of Nov 11 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Health Catalyst Inc grew revenues 7.13% from 276.24m to 295.94m while net income improved from a loss of 137.40m to a smaller loss of 118.15m.
Gross margin46.17%
Net profit margin-26.20%
Operating margin-28.17%
Return on assets-10.37%
Return on equity-21.46%
Return on investment-14.16%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Health Catalyst Inc fell by 10.04m. However, Cash Flow from Investing totalled 20.29m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 33.08m for operations while cash generated from financing totalled 2.73m.
Cash flow per share-0.6402
Price/Cash flow per share--
Book value per share5.83
Tangible book value per share0.7262
More ▼

Balance sheet in USDView more

Health Catalyst Inc has a Debt to Total Capital ratio of 49.29%, a lower figure than the previous year's 59.53%.
Current ratio1.41
Quick ratio--
Total debt/total equity0.9718
Total debt/total capital0.4929
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.